• Enovix reaffirmed Q3 2026 guidance despite a CEO transition, keeping its outlook unchanged.
• Revenue forecast at $9 million-$10 million, implying 13%-25% year-on-year growth.
• Non-GAAP operating loss expected at $29 million-$32 million; non-GAAP net loss per share seen at $0.13-$0.17.
• Capital expenditures projected at $8 million-$12 million; cash, cash equivalents and marketable securities totaled about $552.1 million at end-Q2 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enovix Corporation published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.